Literature DB >> 28509298

A rare case: childhood-onset C3 glomerulonephritis due to homozygous factor H deficiency.

Krisztina Rusai1, Vera Zaller2, Agnes Szilagyi3, Renate Kain4, Zoltan Prohaszka3, H Terence Cook5, Christoph Aufricht2, Klaus Arbeiter2.   

Abstract

C3 glomerulopathy is a recently described pathological entity including dense deposit disease and C3 glomerulonephritis (C3GN). In some cases, C3 glomerulopathy is associated with defects or even complete deficiency of factor H. However, complete factor H deficiency among patients with C3GN is rare, and paediatric cases have not yet been described. Here, we report a child with homozygous factor H deficiency who presented with haematuria and minor proteinuria, together with undetectable plasma C3 levels, at the age of 10 years. Kidney biopsy demonstrated C3GN. Detailed complement analysis revealed complete factor H deficiency due to a homozygous CFH mutation. Furthermore, there was a complete deletion of CFHR-1/-3. During follow-up, the patient has had recurrent episodes of macro-haematuria and minor proteinuria, but during 4 years of follow-up, no deterioration of renal function has been observed. Mutations of factor H in C3GN have been described; however, complete CFH deficiency is rare in these patients. Furthermore, clinical presentation usually occurs in adulthood. Therefore, this case presents a rare manifestation of the disease and might contribute to the early detection of similar cases also in childhood.

Entities:  

Keywords:  C3 glomerulonephritis; Childhood; Factor H deficiency

Year:  2013        PMID: 28509298      PMCID: PMC5411554          DOI: 10.1007/s13730-013-0070-5

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  16 in total

1.  Eculizumab for dense deposit disease and C3 glomerulonephritis.

Authors:  Andrew S Bomback; Richard J Smith; Gaetano R Barile; Yuzhou Zhang; Eliot C Heher; Leal Herlitz; M Barry Stokes; Glen S Markowitz; Vivette D D'Agati; Pietro A Canetta; Jai Radhakrishnan; Gerald B Appel
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-08       Impact factor: 8.237

2.  Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism.

Authors:  B H Ault; B Z Schmidt; N L Fowler; C E Kashtan; A E Ahmed; B A Vogt; H R Colten
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

3.  C3 deposition glomerulopathy due to a functional factor H defect.

Authors:  Sandra Habbig; Michael J Mihatsch; Stefan Heinen; Bodo Beck; Mathias Emmel; Christine Skerka; Michael Kirschfink; Bernd Hoppe; Peter F Zipfel; Christoph Licht
Journal:  Kidney Int       Date:  2008-07-16       Impact factor: 10.612

4.  Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Authors:  Aude Servais; Véronique Frémeaux-Bacchi; Moglie Lequintrec; Rémi Salomon; Jacques Blouin; Bertrand Knebelmann; Jean-Pierre Grünfeld; Philippe Lesavre; Laure-Hélène Noël; Fadi Fakhouri
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

5.  Disruption of disulfide bonds is responsible for impaired secretion in human complement factor H deficiency.

Authors:  B Z Schmidt; N L Fowler; T Hidvegi; D H Perlmutter; H R Colten
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 6.  Complement and glomerular disease: new insights.

Authors:  Matthew Pickering; H Terence Cook
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-05       Impact factor: 2.894

7.  Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.

Authors:  Aude Servais; Laure-Hélène Noël; Marie-Agnes Dragon-Durey; Marie-Claire Gübler; Philippe Rémy; David Buob; Carole Cordonnier; Raïfah Makdassi; Waddah Jaber; Eric Boulanger; Philippe Lesavre; Véronique Frémeaux-Bacchi
Journal:  Hum Pathol       Date:  2011-03-10       Impact factor: 3.466

8.  Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality.

Authors:  Angela Gerber; Antje H Kirchhoff-Moradpour; Silke Obieglo; Matthias Brandis; Michael Kirschfink; Peter F Zipfel; Judith A Goodship; Lothar B Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

9.  The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.

Authors:  M-A Dragon-Durey; C Blanc; F Marliot; C Loirat; J Blouin; C Sautes-Fridman; W H Fridman; V Frémeaux-Bacchi
Journal:  J Med Genet       Date:  2009-05-11       Impact factor: 6.318

10.  Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.

Authors:  Peter F Zipfel; Matthew Edey; Stefan Heinen; Mihály Józsi; Heiko Richter; Joachim Misselwitz; Bernd Hoppe; Danny Routledge; Lisa Strain; Anne E Hughes; Judith A Goodship; Christoph Licht; Timothy H J Goodship; Christine Skerka
Journal:  PLoS Genet       Date:  2007-02-01       Impact factor: 5.917

View more
  2 in total

1.  C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.

Authors:  Yuzhou Zhang; Adam Keenan; Dao-Fu Dai; Kristofer S May; Emily E Anderson; Margaret A Lindorfer; John B Henrich; Gabriella R Pitcher; Ronald P Taylor; Richard Jh Smith
Journal:  JCI Insight       Date:  2020-05-07

2.  Humanized C3 Mouse: A Novel Accelerated Model of C3 Glomerulopathy.

Authors:  Kishor Devalaraja-Narashimha; Karoline Meagher; Yifan Luo; Cong Huang; Theodore Kaplan; Anantharaman Muthuswamy; Gabor Halasz; Sarah Casanova; John O'Brien; Rebecca Peyser Boiarsky; John McWhirter; Hans Gartner; Yu Bai; Scott MacDonnell; Chien Liu; Ying Hu; Adrianna Latuszek; Yi Wei; Srinivasa Prasad; Tammy Huang; George Yancopoulos; Andrew Murphy; William Olson; Brian Zambrowicz; Lynn Macdonald; Lori G Morton
Journal:  J Am Soc Nephrol       Date:  2020-12-07       Impact factor: 10.121

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.